CAMBRIDGE, Mass., Jan. 3 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview, including an update of the company’s commercialization activities and discovery and development programs, at the upcoming JP Morgan 25th Annual Healthcare Conference on Tuesday, January 9, 2007 at 3:00 p.m. PST at the Westin St. Francis in San Francisco.
The live and archived webcast of the presentation can be accessed under “Calendar of Events” in the Idenix Investor Center at http://ir.idenix.com/phoenix.zhtml?c=131556&p=irol-calendar. Please log in approximately 10 minutes before the call to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the presentation.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals’ Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman, +1-617-995-9905, or Investors, Amy Sullivan,+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.
